| Product Code: ETC12012277 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Latvia saw a steady flow of drug imports for schistosomiasis treatment from key exporting countries such as Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the diverse sources, the market remained competitive with low concentration levels, as indicated by the Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at a healthy 8.6%, demonstrating sustained market expansion. Moreover, the growth rate from 2023 to 2024 was notable at 7.03%, reflecting a positive trend in the importation of drugs for combating schistosomiasis in Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Drugs for Schistosomiasis Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Drugs for Schistosomiasis Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Drugs for Schistosomiasis Market - Industry Life Cycle |
3.4 Latvia Drugs for Schistosomiasis Market - Porter's Five Forces |
3.5 Latvia Drugs for Schistosomiasis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Latvia Drugs for Schistosomiasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Latvia Drugs for Schistosomiasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Drugs for Schistosomiasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Latvia Drugs for Schistosomiasis Market Trends |
6 Latvia Drugs for Schistosomiasis Market, By Types |
6.1 Latvia Drugs for Schistosomiasis Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Praziquantel, 2021 - 2031F |
6.1.4 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Oxamniquine, 2021 - 2031F |
6.1.5 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Metrifonate, 2021 - 2031F |
6.1.6 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Artesunate, 2021 - 2031F |
6.2 Latvia Drugs for Schistosomiasis Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.2.3 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.2.4 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.2.5 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Government Programs, 2021 - 2031F |
6.3 Latvia Drugs for Schistosomiasis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.3.5 Latvia Drugs for Schistosomiasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
7 Latvia Drugs for Schistosomiasis Market Import-Export Trade Statistics |
7.1 Latvia Drugs for Schistosomiasis Market Export to Major Countries |
7.2 Latvia Drugs for Schistosomiasis Market Imports from Major Countries |
8 Latvia Drugs for Schistosomiasis Market Key Performance Indicators |
9 Latvia Drugs for Schistosomiasis Market - Opportunity Assessment |
9.1 Latvia Drugs for Schistosomiasis Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Latvia Drugs for Schistosomiasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Latvia Drugs for Schistosomiasis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Drugs for Schistosomiasis Market - Competitive Landscape |
10.1 Latvia Drugs for Schistosomiasis Market Revenue Share, By Companies, 2024 |
10.2 Latvia Drugs for Schistosomiasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |